The International Viral Hepatitis Elimination Meeting (IVHEM) to be held in Amsterdam on the 17-18th November 2017 is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress toward elimination of viral hepatitis as a public health threat by 2030.
- Registration is now open. Click here to register
- Want to stay informed on IVHEM 2017? Click here to subscribe to the IVHEM newsletter
- IVHEM is endorsed by more than 25 (inter)national organizations. Their support and collaboration are key to the success of this conference. Find out more on endorsements
- Missed IVHEM 2016? Find presentations and webcasts HERE.
Introduction by meeting chairs 2017
Hepatitis B and C affect more than 320 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 248 million people (3.8% of the world’s population) are chronically infected with HBV, and over 700,000 attributable deaths annually. An estimated 80 million people (globally, 1.1%) are chronically infected with hepatitis C virus (HCV), resulting in nearly 500,000 deaths annually.
Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two day meeting experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis, and increase the number of people accessing testing and treatment.
Involving community organisations, researchers, public health practitioners and clinicians, the program includes practical examples of innovative intervention studies, country elimination programs and novel funding mechanisms testing and treatment, all focusing on meeting the 2030 targets.
We invite you to contribute to elimination of viral hepatitis and look forward to welcoming you to this unique meeting in Amsterdam!
Meeting Chairs IVHEM 2017